医学
安慰剂
螯合疗法
心肌梗塞
内科学
糖尿病
冲程(发动机)
外科
内分泌学
病理
机械工程
地中海贫血
替代医学
工程类
作者
Gervasio A. Lamas,Kevin J. Anstrom,Ana Navas‐Acién,Robin Boineau,Hayley Nemeth,Zhen Huang,Jun Wen,Yves Rosenberg,Mario Stylianou,Teresa L.Z. Jones,Bonnie R. Joubert,Qilu Yu,Regina M. Santella,Ana C. Mon,Francisco Ujueta,Esteban Escolar,David M. Nathan,Vivian Fonseca,Y. Wady Aude,Jonathan K. Ehrman
出处
期刊:JAMA
[American Medical Association]
日期:2024-08-14
卷期号:332 (10): 794-794
被引量:12
标识
DOI:10.1001/jama.2024.11463
摘要
In 2013, the Trial to Assess Chelation Therapy (TACT) reported that edetate disodium (EDTA)-based chelation significantly reduced cardiovascular disease (CVD) events by 18% in 1708 patients with a prior myocardial infarction (MI).
科研通智能强力驱动
Strongly Powered by AbleSci AI